Commercial Diagnostics · MedTech & Healthcare AI

why medtech deals stall.

Commercial diagnostics for post-clearance MedTech and healthcare AI companies. I find where your deals die, why, and what to fix first.

01 — The Problem

You cleared FDA. Clinicians love the demo. The pipeline is full of verbal yeses. Nothing converts. The board is asking why, and the honest answer is you don’t know yet.

02 — The Offer

The Commercial Diagnostic

3 weeks$15,000

A full-field diagnosis of your stalled pipeline: where deals die, why, and a prioritized fix plan.

What’s included

01Deal-by-deal review of your stalled pipeline
02Rep and champion interviews
03VAC and reimbursement pathway analysis
04Written findings and a working session to walk your team through them

04 — Who this is for

Series A or B MedTech or imaging AI.
Post-FDA clearance, 12 to 30 months into commercialization.
Missing your number and tired of guessing why.

05 — Why Me

From the halls of the hospital to the boardroom.

15+ years clinical-to-commercial. I started as a radiological technologist and cardiac scrub tech in ORs, cath labs, and trauma centers.

Then I ranked #1 of 204 nationally selling capital imaging for a Fortune 500 healthcare company, and went on to lead commercial teams at five MedTech and healthcare AI startups.

I’ve watched deals stall from both sides of the wall: the clinicians who won’t adopt and the sales orgs that can’t see why. That’s the stall I find.